Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test
Editorial Group: Cochrane Gynaecological Cancer Group
Published Online: 3 OCT 2013
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
van der Heijden E, Lopes AD, Bryant A, Bekkers R, Galaal K, Das N. Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010757. DOI: 10.1002/14651858.CD010757.
- Publication Status: Edited (no change to conclusions)
- Published Online: 3 OCT 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
- To evaluate the risk of developing recurrent cervical intraepithelial neoplasia 2+ (CIN2+) in women with a positive high risk human papilloma virus (HPV) test after large loop excision of the transformation zone (LLETZ) treatment
- To determine the optimal follow-up strategies for women following LLETZ treatment according to high risk HPV status